Inhibition of duck hepatitis B virus replication by purine 2',3'-dideoxynucleosides (Q45833388)

16 December 2017

title

Inhibition of duck hepatitis B virus replication by purine 2',3'-dideoxynucleosides (English)

1 reference

16 December 2017

1 reference

Suzuki S

1

1 reference

16 December 2017

Lee B

2

1 reference

16 December 2017

Luo W

3

1 reference

16 December 2017

Tovell D

4

1 reference

16 December 2017

Robins MJ

5

1 reference

16 December 2017

Tyrrell DL

6

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 November 1988

1 reference

16 December 2017

Biochemical and Biophysical Research Communications

published in

1 reference

16 December 2017

volume

156

1 reference

16 December 2017

page(s)

1144-1151

1 reference

16 December 2017

issue

3

1 reference

16 December 2017

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2980752-6

NIH conference. Hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2980752-6

Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2980752-6

Interferon in viral hepatitis: role in pathogenesis and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2980752-6

Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine Arabinoside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2980752-6

Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2980752-6

Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2980752-6

Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2980752-6

Hepatitis B virus contains protein attached to the 5' terminus of its complete DNA strand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2980752-6

Detection of specific sequences among DNA fragments separated by gel electrophoresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2980752-6

Investigations on the anti-HIV activity of 2',3'-dideoxyadenosine analogues with modifications in either the pentose or purine moiety. Potent and selective anti-HIV activity of 2,6-diaminopurine 2',3'-dideoxyriboside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2980752-6

The molecular biology of the hepatitis B viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2980752-6

In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2980752-6

10.1016/S0006-291X(88)80752-6

7 January 2021

Identifiers

DOI

1 reference

16 December 2017

PubMed ID

3190693

1 reference

16 December 2017